Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Oxybate for Voice Tremor in Spasmodic Dysphonia
NCT01961297Phase 2Completed
- Start
- Jul 2012
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sodium oxybate in Spasmodic dysphonia (SD) and essential voice tremor (EVT). Primary endpoint: Number of Participants Who Reported Positive Effects at Day 1. Started Jul 2012; status: completed.
02
Drugs
sodium oxybate
03
Conditions
Spasmodic dysphonia (SD)essential voice tremor (EVT)
Beyond the preview
Go deeper on NCT01961297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01961297.